BUZZ-Neuropace falls on discounted pricing of public offering

Shares of medical device maker Neuropace NPCE.O fall 16.54% to $10.09

Co announces the pricing of $65 million of common stock

Co plans to offers 6.5 million shares at a public offering price of $10.00 per share; 17.3% discount to last closing price

Grants underwriters a 30-day option to purchase up to an additional 975,000 shares of its common stock at the public offering price

The offering is expected to close on February 18

Co has 29.85 mln shares outstanding, giving it a ~360 mln market cap - data compiled from LSEG

The stock has fallen ~27% in the last 12 months